AOD 9604 is a synthetic peptide from the C-terminus of human growth hormone, developed to reduce fat without the side effects of full HGH. It promotes lipolysis and inhibits lipogenesis, aiding weight management. While promising for its targeted action in fat loss, it requires further research and should be used under medical guidance to ensure safety and efficacy.
AOD 9604 is a synthetic peptide derived from human growth hormone, composed of amino acids 177-191. It has garnered interest for its fat-reducing properties without the broad metabolic effects associated with HGH. While it may boost fat breakdown and curb fat accumulation, limited clinical evidence exists regarding its safety and effectiveness. Regulatory status varies, with it often being marketed as a research chemical. Bodies like WADA monitor its use due to potential performance-enhancing capabilities. Comprehensive studies are crucial to grasping its benefits and risks fully.
